To explore an effective strategy for late-stage HCC treatment, the hemi-spleen inoculation of Hepa1-6 based on CCl4-induced fibrosis model was used to test the therapeutic effect of simvastatin NPs combined with PD-L1 antibody. The gene discussed is CD274; the disease is hepatocellular carcinoma.